ENTO ENTERO THERAPEUTICS INC Business Restructuring 8-K Filing 2024 - Amendment to Form 8-K First Wave Biopharma, Inc. filed an Amendment to their Form 8-K to include financial statements and pro forma financial information related to their merger with ImmunogenX, Inc.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC